ITGAX and type 1 diabetes mellitus: SIRPα has been shown to have a possible role in auto-immunity having been found to be a risk loci in individuals with Type 1 Diabetes (38), and Crohn's patients have increased SIRPα/β+CD11C+DCs in the mesenteric lymph nodes and inflamed intestinal mucosa (39).